Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease
Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of rare protein-altering variants in 7 genes where common variants were previously associated with T1R. We selected 474 Vietnamese leprosy patient...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 116; no. 31; pp. 15616 - 15624 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
30.07.2019
|
Series | PNAS Plus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of rare protein-altering variants in 7 genes where common variants were previously associated with T1R. We selected 474 Vietnamese leprosy patients of which 237 were T1R-affected and 237 were T1R-free matched controls. Genewise enrichment of nonsynonymous variants was tested with both kernel-based (sequence kernel association test [SKAT]) and burden methods. Of the 7 genes tested 2 showed statistical evidence of association with T1R. For the LRRK2 gene an enrichment of nonsynonymous variants was observed in T1R-free controls (P
SKAT-O = 1.6 × 10−4). This genewise association was driven almost entirely by the gain-of-function variant R1628P (P = 0.004; odds ratio = 0.29). The second genewise association was found for the Parkin coding gene PRKN (formerly PARK2) where 7 rare variants were enriched in T1R-affected cases (P
SKAT-O = 7.4 × 10−5). Mutations in both PRKN and LRRK2 are known causes of Parkinson’s disease (PD). Hence, we evaluated to what extent such rare amino acid changes observed in T1R are shared with PD. We observed that amino acids in Parkin targeted by nonsynonymous T1R-risk mutations were also enriched for mutations implicated in PD (P = 1.5 × 10−4). Hence, neuroinflammation in PD and peripheral nerve damage due to inflammation in T1R share overlapping genetic control of pathogenicity. |
---|---|
AbstractList | Type-1 reactions (T1R) are pathological immune responses in leprosy and a frequent cause of peripheral nerve damage. Employing a candidate gene approach combined with deep resequencing, we identified amino acid mutations in the E3 ligase Parkin and the polyfunctional kinase LRRK2 that were associated with T1R. This finding directly linked both proteins with the extent of the immune response in an infectious disease. Moreover, amino acids associated with T1R mutations were significantly enriched for mutations found in patients suffering from Parkinson’s disease (PD). These findings confirm Parkin and LRRK2 as 2 key inflammatory regulators and suggest that T1R and PD share overlapping pathways of pathogenesis.
Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of rare protein-altering variants in 7 genes where common variants were previously associated with T1R. We selected 474 Vietnamese leprosy patients of which 237 were T1R-affected and 237 were T1R-free matched controls. Genewise enrichment of nonsynonymous variants was tested with both kernel-based (sequence kernel association test [SKAT]) and burden methods. Of the 7 genes tested 2 showed statistical evidence of association with T1R. For the
LRRK2
gene an enrichment of nonsynonymous variants was observed in T1R-free controls (
P
SKAT-O
= 1.6 × 10
−4
). This genewise association was driven almost entirely by the gain-of-function variant R1628P (
P
= 0.004; odds ratio = 0.29). The second genewise association was found for the Parkin coding gene
PRKN
(formerly
PARK2
) where 7 rare variants were enriched in T1R-affected cases (
P
SKAT-O
= 7.4 × 10
−5
). Mutations in both
PRKN
and
LRRK2
are known causes of Parkinson’s disease (PD). Hence, we evaluated to what extent such rare amino acid changes observed in T1R are shared with PD. We observed that amino acids in Parkin targeted by nonsynonymous T1R-risk mutations were also enriched for mutations implicated in PD (
P
= 1.5 × 10
−4
). Hence, neuroinflammation in PD and peripheral nerve damage due to inflammation in T1R share overlapping genetic control of pathogenicity. Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of rare protein-altering variants in 7 genes where common variants were previously associated with T1R. We selected 474 Vietnamese leprosy patients of which 237 were T1R-affected and 237 were T1R-free matched controls. Genewise enrichment of nonsynonymous variants was tested with both kernel-based (sequence kernel association test [SKAT]) and burden methods. Of the 7 genes tested 2 showed statistical evidence of association with T1R. For the LRRK2 gene an enrichment of nonsynonymous variants was observed in T1R-free controls (P SKAT-O = 1.6 × 10−4). This genewise association was driven almost entirely by the gain-of-function variant R1628P (P = 0.004; odds ratio = 0.29). The second genewise association was found for the Parkin coding gene PRKN (formerly PARK2) where 7 rare variants were enriched in T1R-affected cases (P SKAT-O = 7.4 × 10−5). Mutations in both PRKN and LRRK2 are known causes of Parkinson’s disease (PD). Hence, we evaluated to what extent such rare amino acid changes observed in T1R are shared with PD. We observed that amino acids in Parkin targeted by nonsynonymous T1R-risk mutations were also enriched for mutations implicated in PD (P = 1.5 × 10−4). Hence, neuroinflammation in PD and peripheral nerve damage due to inflammation in T1R share overlapping genetic control of pathogenicity. Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of rare protein-altering variants in 7 genes where common variants were previously associated with T1R. We selected 474 Vietnamese leprosy patients of which 237 were T1R-affected and 237 were T1R-free matched controls. Genewise enrichment of nonsynonymous variants was tested with both kernel-based (sequence kernel association test [SKAT]) and burden methods. Of the 7 genes tested 2 showed statistical evidence of association with T1R. For the gene an enrichment of nonsynonymous variants was observed in T1R-free controls ( = 1.6 × 10 ). This genewise association was driven almost entirely by the gain-of-function variant R1628P ( = 0.004; odds ratio = 0.29). The second genewise association was found for the Parkin coding gene (formerly ) where 7 rare variants were enriched in T1R-affected cases ( = 7.4 × 10 ). Mutations in both and are known causes of Parkinson's disease (PD). Hence, we evaluated to what extent such rare amino acid changes observed in T1R are shared with PD. We observed that amino acids in Parkin targeted by nonsynonymous T1R-risk mutations were also enriched for mutations implicated in PD ( = 1.5 × 10 ). Hence, neuroinflammation in PD and peripheral nerve damage due to inflammation in T1R share overlapping genetic control of pathogenicity. Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of rare protein-altering variants in 7 genes where common variants were previously associated with T1R. We selected 474 Vietnamese leprosy patients of which 237 were T1R-affected and 237 were T1R-free matched controls. Genewise enrichment of nonsynonymous variants was tested with both kernel-based (sequence kernel association test [SKAT]) and burden methods. Of the 7 genes tested 2 showed statistical evidence of association with T1R. For the LRRK2 gene an enrichment of nonsynonymous variants was observed in T1R-free controls (PSKAT-O = 1.6 × 10−4). This genewise association was driven almost entirely by the gain-of-function variant R1628P (P = 0.004; odds ratio = 0.29). The second genewise association was found for the Parkin coding gene PRKN (formerly PARK2) where 7 rare variants were enriched in T1R-affected cases (PSKAT-O = 7.4 × 10−5). Mutations in both PRKN and LRRK2 are known causes of Parkinson's disease (PD). Hence, we evaluated to what extent such rare amino acid changes observed in T1R are shared with PD. We observed that amino acids in Parkin targeted by nonsynonymous T1R-risk mutations were also enriched for mutations implicated in PD (P = 1.5 × 10−4). Hence, neuroinflammation in PD and peripheral nerve damage due to inflammation in T1R share overlapping genetic control of pathogenicity. |
Author | Tao, Shao Cobat, Aurélie Lettre, Guillaume MacDougall, Emma J. Schurr, Erwin Lahiri, Ramanuj Adams, Linda Thai, Vu Hong Xu, Yong Zhong Cambri, Geison Trempe, Jean-François Eldeeb, Mohamed A. Orlova, Marianna Croteau, Nathalie Fon, Edward A. Abel, Laurent Fava, Vinicius M. Van Thuc, Nguyen Alcaïs, Alexandre |
Author_xml | – sequence: 1 givenname: Vinicius M. surname: Fava fullname: Fava, Vinicius M. – sequence: 2 givenname: Yong Zhong surname: Xu fullname: Xu, Yong Zhong – sequence: 3 givenname: Guillaume surname: Lettre fullname: Lettre, Guillaume – sequence: 4 givenname: Nguyen surname: Van Thuc fullname: Van Thuc, Nguyen – sequence: 5 givenname: Marianna surname: Orlova fullname: Orlova, Marianna – sequence: 6 givenname: Vu Hong surname: Thai fullname: Thai, Vu Hong – sequence: 7 givenname: Shao surname: Tao fullname: Tao, Shao – sequence: 8 givenname: Nathalie surname: Croteau fullname: Croteau, Nathalie – sequence: 9 givenname: Mohamed A. surname: Eldeeb fullname: Eldeeb, Mohamed A. – sequence: 10 givenname: Emma J. surname: MacDougall fullname: MacDougall, Emma J. – sequence: 11 givenname: Geison surname: Cambri fullname: Cambri, Geison – sequence: 12 givenname: Ramanuj surname: Lahiri fullname: Lahiri, Ramanuj – sequence: 13 givenname: Linda surname: Adams fullname: Adams, Linda – sequence: 14 givenname: Edward A. surname: Fon fullname: Fon, Edward A. – sequence: 15 givenname: Jean-François surname: Trempe fullname: Trempe, Jean-François – sequence: 16 givenname: Aurélie surname: Cobat fullname: Cobat, Aurélie – sequence: 17 givenname: Alexandre surname: Alcaïs fullname: Alcaïs, Alexandre – sequence: 18 givenname: Laurent surname: Abel fullname: Abel, Laurent – sequence: 19 givenname: Erwin surname: Schurr fullname: Schurr, Erwin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31308240$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkctuFDEQRS0URCaBNSuQJTZsOqlyv-wNEop4iZGIIthiedxl8NBjd-wepNnxG_weX4LDhOGxKpXq1L0u3xN2FGIgxh4inCH09fkUTD5DBSihRezusAWCwqprFByxBYDoK9mI5pid5LwGANVKuMeOa6xBigYW7OPlSD7OKU7ecnKO7Jy5i4lfmvTFB27CwJdXV28FL81IU4p5x-fdRBXyRMbOPob8i9ov5Bh-fPue-eAzmUz32V1nxkwPbusp-_DyxfuL19Xy3as3F8-XlW1BzVXrGtmuajTGDGCV6KFrcXC2hwZsvTISULmVpEFaaZEEOYW2UUr14AbRDfUpe7bXnbarDQ2WwpzMqKfkNybtdDRe_zsJ_rP-FL_qrpNYXIrA01uBFK-3lGe98dnSOJpAcZu1EK3sa9lLWdAn_6HruE2hnFeoThbBrlWFOt9TtnxZTuQOj0HQN9npm-z0n-zKxuO_bzjwv8MqwKM9sM5zTId58WyKJ9Q_ASUTolo |
CitedBy_id | crossref_primary_10_1371_journal_ppat_1008565 crossref_primary_10_3389_fimmu_2021_714808 crossref_primary_10_1073_pnas_2000533117 crossref_primary_10_1111_cge_13945 crossref_primary_10_1016_j_envpol_2024_123643 crossref_primary_10_1371_journal_pntd_0010029 crossref_primary_10_3389_fimmu_2020_00567 crossref_primary_10_1371_journal_ppat_1008818 crossref_primary_10_3389_fimmu_2024_1298749 crossref_primary_10_1007_s00281_020_00790_4 crossref_primary_10_3389_fnins_2020_00193 crossref_primary_10_1016_j_ceb_2020_01_001 crossref_primary_10_1128_MCB_00660_20 crossref_primary_10_1073_pnas_2313540121 crossref_primary_10_1111_imr_12962 crossref_primary_10_1002_pep2_24251 crossref_primary_10_1126_scisignal_aav1256 crossref_primary_10_1016_j_nbd_2022_105806 crossref_primary_10_1371_journal_pntd_0008247 crossref_primary_10_3390_ijms22031045 crossref_primary_10_7326_aimcc_2022_0914 crossref_primary_10_1038_s41577_022_00684_6 crossref_primary_10_26508_lsa_202201419 crossref_primary_10_3389_fimmu_2021_647832 crossref_primary_10_1016_j_nbd_2022_105724 crossref_primary_10_1042_BST20180463 crossref_primary_10_1073_pnas_2002654117 crossref_primary_10_3389_fmed_2021_694376 crossref_primary_10_3389_fnins_2020_00443 crossref_primary_10_3389_fmed_2023_1233220 crossref_primary_10_3390_biom11081101 crossref_primary_10_1371_journal_ppat_1011260 crossref_primary_10_1016_j_arr_2021_101396 crossref_primary_10_1007_s12640_021_00396_0 crossref_primary_10_1016_j_ejmech_2023_115475 crossref_primary_10_1007_s00439_019_02087_5 crossref_primary_10_1007_s00439_020_02163_1 crossref_primary_10_1016_j_tins_2021_06_006 crossref_primary_10_1007_s00294_020_01062_2 crossref_primary_10_1016_j_jmb_2023_168090 crossref_primary_10_1016_j_str_2021_01_001 crossref_primary_10_1080_02648725_2023_2168509 |
Cites_doi | 10.1038/srep35171 10.1101/gr.107524.110 10.1038/nature12566 10.1016/S1353-8020(00)00018-3 10.1001/archneur.60.9.1253 10.1590/S0074-02762012000900020 10.1002/1531-8249(199905)45:5<655::AID-ANA15>3.0.CO;2-G 10.1016/S0014-5793(03)01271-7 10.1093/nar/29.1.308 10.1111/cns.12062 10.1016/j.cell.2016.05.039 10.1016/j.ajhg.2010.04.005 10.1002/mds.20343 10.1136/jmg.2007.051854 10.1086/509923 10.1371/journal.pgen.1003624 10.1038/s41594-018-0088-7 10.1093/infdis/jiu566 10.1001/archneur.62.1.82 10.1371/journal.pone.0149739 10.15252/embr.201744981 10.1016/j.neulet.2016.04.056 10.1038/nature02326 10.3389/fimmu.2017.00155 10.1016/j.parkreldis.2012.01.021 10.1038/ng2000 10.1038/ng.973 10.1038/ncomms12177 10.3389/fnmol.2017.00120 10.1093/nar/gkq603 10.1016/j.parkreldis.2006.04.005 10.1590/S0365-05962008000100010 10.1016/j.neurobiolaging.2009.11.019 10.1002/mds.21262 10.1371/journal.pntd.0004412 10.1016/j.freeradbiomed.2015.08.030 10.1001/archneur.65.4.467 10.1016/S1474-4422(11)70175-2 10.1126/scitranslmed.aai7795 10.1212/WNL.56.4.463 10.1007/s00415-005-0638-x 10.1016/j.ajhg.2012.06.007 10.1002/humu.21438 10.1002/humu.22117 10.1038/ncomms14697 10.1038/nri1943 10.1016/j.parkreldis.2005.12.004 10.1056/NEJMoa0903753 10.1097/00001756-199909090-00008 10.1093/nar/gkw971 10.1007/s10038-008-0336-5 10.1016/j.parkreldis.2007.10.003 10.1111/j.1365-2249.2006.03087.x 10.1038/ncomms13760 10.1086/651559 10.1086/519795 10.1038/ng.491 10.1086/524688 10.1093/hmg/ddz080 10.1038/nature12555 10.1002/mds.22514 10.1002/mds.22287 10.1111/j.1468-1331.2011.03639.x 10.1016/j.neulet.2009.10.080 10.1038/srep09029 10.1002/ajmg.b.32138 10.1097/WNR.0b013e328010521c 10.1371/journal.pgen.1006637 10.1126/science.1237908 10.1002/ana.21405 10.1093/infdis/jis208 10.1371/journal.pntd.0000231 10.1371/journal.pgen.1003578 10.1001/archneur.63.4.548 |
ContentType | Journal Article |
Copyright | Copyright © 2019 the Author(s). Published by PNAS. Copyright National Academy of Sciences Jul 30, 2019 Copyright © 2019 the Author(s). Published by PNAS. 2019 |
Copyright_xml | – notice: Copyright © 2019 the Author(s). Published by PNAS. – notice: Copyright National Academy of Sciences Jul 30, 2019 – notice: Copyright © 2019 the Author(s). Published by PNAS. 2019 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1073/pnas.1901805116 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts Ecology Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Entomology Abstracts Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 15624 |
ExternalDocumentID | 10_1073_pnas_1901805116 31308240 26848160 |
Genre | Multicenter Study Clinical Trial Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: CIHR grantid: FDN-154301 – fundername: CIHR grantid: FDN-143332 – fundername: Canada Research Chairs (Chaires de recherche du Canada) grantid: 229792 – fundername: Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) grantid: 143332 – fundername: Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) grantid: 154301 |
GroupedDBID | --- -DZ -~X .55 0R~ 123 29P 2AX 2FS 2WC 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACIWK ACNCT ACPRK ADACV ADULT AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM BKOMP CS3 D0L DCCCD DIK DOOOF DU5 E3Z EBS EJD F5P FRP GX1 H13 HH5 HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 N9A N~3 O9- OK1 PNE PQQKQ R.V RHF RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VQA W8F WH7 WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ~02 ~KM CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c509t-5f485b31aaad0c9270651dfc7040c3ba8019fb8ed8c8c1e2ef91c499970fd26d3 |
IEDL.DBID | RPM |
ISSN | 0027-8424 |
IngestDate | Tue Sep 17 21:26:19 EDT 2024 Fri Oct 25 04:43:23 EDT 2024 Thu Oct 10 18:15:18 EDT 2024 Fri Dec 06 02:51:13 EST 2024 Tue Aug 27 13:48:55 EDT 2024 Tue Dec 10 23:55:29 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 31 |
Keywords | leprosy type-1 reaction inflammation LRRK2 Parkinson’s disease Parkin |
Language | English |
License | Copyright © 2019 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c509t-5f485b31aaad0c9270651dfc7040c3ba8019fb8ed8c8c1e2ef91c499970fd26d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 1V.M.F. and E.S. contributed equally to this work. Edited by Lalita Ramakrishnan, University of Cambridge, Cambridge, United Kingdom, and approved June 21, 2019 (received for review February 1, 2019) Author contributions: V.M.F., Y.Z.X., G.L., E.A.F., J.-F.T., L. Abel, and E.S. designed research; V.M.F., Y.Z.X., S.T., N.C., M.A.E., E.J.M., E.A.F., J.-F.T., A.C., A.A., L. Abel, and E.S. performed research; V.M.F., Y.Z.X., N.V.T., M.O., V.H.T., S.T., G.C., R.L., L. Adams, J.-F.T., and E.S. contributed new reagents/analytic tools; V.M.F., Y.Z.X., G.L., S.T., M.A.E., E.J.M., E.A.F., J.-F.T., A.C., A.A., L. Abel, and E.S. analyzed data; and V.M.F., Y.Z.X., G.L., M.O., E.A.F., J.-F.T., A.C., A.A., L. Abel, and E.S. wrote the paper. |
ORCID | 0000-0002-7548-1940 0000-0001-9142-1713 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681704/ |
PMID | 31308240 |
PQID | 2268681659 |
PQPubID | 42026 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6681704 proquest_miscellaneous_2258738788 proquest_journals_2268681659 crossref_primary_10_1073_pnas_1901805116 pubmed_primary_31308240 jstor_primary_26848160 |
PublicationCentury | 2000 |
PublicationDate | 2019-07-30 |
PublicationDateYYYYMMDD | 2019-07-30 |
PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationSeriesTitle | PNAS Plus |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 2019 |
Publisher | National Academy of Sciences |
Publisher_xml | – sequence: 0 name: National Academy of Sciences – name: National Academy of Sciences |
References | e_1_3_3_50_2 e_1_3_3_75_2 e_1_3_3_71_2 e_1_3_3_77_2 e_1_3_3_79_2 Tan E. K. (e_1_3_3_28_2) 2010; 31 e_1_3_3_16_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_58_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_56_2 e_1_3_3_33_2 e_1_3_3_54_2 e_1_3_3_10_2 e_1_3_3_52_2 e_1_3_3_73_2 e_1_3_3_40_2 e_1_3_3_61_2 Yang Y. (e_1_3_3_31_2) 2015; 2 e_1_3_3_5_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_48_2 e_1_3_3_69_2 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_67_2 e_1_3_3_80_2 e_1_3_3_44_2 e_1_3_3_65_2 Tomiyama H. (e_1_3_3_74_2) 2006; 21 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 e_1_3_3_63_2 e_1_3_3_51_2 e_1_3_3_76_2 e_1_3_3_70_2 e_1_3_3_78_2 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_59_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_57_2 Fava V. M. (e_1_3_3_1_2) 2016 e_1_3_3_32_2 e_1_3_3_55_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_53_2 e_1_3_3_72_2 e_1_3_3_62_2 e_1_3_3_60_2 WHO (e_1_3_3_7_2) 2016 WHO (e_1_3_3_23_2) 2018; 93 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_49_2 e_1_3_3_24_2 e_1_3_3_47_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_68_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_66_2 e_1_3_3_81_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_64_2 |
References_xml | – ident: e_1_3_3_78_2 doi: 10.1038/srep35171 – ident: e_1_3_3_45_2 doi: 10.1101/gr.107524.110 – ident: e_1_3_3_32_2 doi: 10.1038/nature12566 – ident: e_1_3_3_61_2 doi: 10.1016/S1353-8020(00)00018-3 – ident: e_1_3_3_67_2 doi: 10.1001/archneur.60.9.1253 – ident: e_1_3_3_8_2 doi: 10.1590/S0074-02762012000900020 – ident: e_1_3_3_66_2 doi: 10.1002/1531-8249(199905)45:5<655::AID-ANA15>3.0.CO;2-G – ident: e_1_3_3_27_2 doi: 10.1016/S0014-5793(03)01271-7 – ident: e_1_3_3_51_2 doi: 10.1093/nar/29.1.308 – ident: e_1_3_3_22_2 doi: 10.1111/cns.12062 – ident: e_1_3_3_44_2 doi: 10.1016/j.cell.2016.05.039 – ident: e_1_3_3_47_2 doi: 10.1016/j.ajhg.2010.04.005 – ident: e_1_3_3_57_2 doi: 10.1002/mds.20343 – ident: e_1_3_3_38_2 doi: 10.1136/jmg.2007.051854 – ident: e_1_3_3_10_2 doi: 10.1086/509923 – volume: 31 start-page: 561 year: 2010 ident: e_1_3_3_28_2 article-title: Multiple LRRK2 variants modulate risk of Parkinson disease: A Chinese multicenter study publication-title: Hum. Mutat. contributor: fullname: Tan E. K. – ident: e_1_3_3_12_2 doi: 10.1371/journal.pgen.1003624 – ident: e_1_3_3_39_2 doi: 10.1038/s41594-018-0088-7 – ident: e_1_3_3_17_2 doi: 10.1093/infdis/jiu566 – ident: e_1_3_3_70_2 doi: 10.1001/archneur.62.1.82 – ident: e_1_3_3_24_2 doi: 10.1371/journal.pone.0149739 – ident: e_1_3_3_40_2 doi: 10.15252/embr.201744981 – ident: e_1_3_3_77_2 doi: 10.1016/j.neulet.2016.04.056 – ident: e_1_3_3_2_2 doi: 10.1038/nature02326 – ident: e_1_3_3_16_2 doi: 10.3389/fimmu.2017.00155 – ident: e_1_3_3_68_2 doi: 10.1016/j.parkreldis.2012.01.021 – ident: e_1_3_3_3_2 doi: 10.1038/ng2000 – ident: e_1_3_3_5_2 doi: 10.1038/ng.973 – ident: e_1_3_3_29_2 doi: 10.1038/ncomms12177 – ident: e_1_3_3_43_2 doi: 10.3389/fnmol.2017.00120 – ident: e_1_3_3_46_2 doi: 10.1093/nar/gkq603 – ident: e_1_3_3_55_2 doi: 10.1016/j.parkreldis.2006.04.005 – ident: e_1_3_3_9_2 doi: 10.1590/S0365-05962008000100010 – ident: e_1_3_3_80_2 doi: 10.1016/j.neurobiolaging.2009.11.019 – ident: e_1_3_3_59_2 doi: 10.1002/mds.21262 – ident: e_1_3_3_19_2 doi: 10.1371/journal.pntd.0004412 – ident: e_1_3_3_30_2 doi: 10.1016/j.freeradbiomed.2015.08.030 – ident: e_1_3_3_37_2 doi: 10.1001/archneur.65.4.467 – ident: e_1_3_3_81_2 doi: 10.1016/S1474-4422(11)70175-2 – ident: e_1_3_3_25_2 doi: 10.1126/scitranslmed.aai7795 – ident: e_1_3_3_56_2 doi: 10.1212/WNL.56.4.463 – ident: e_1_3_3_63_2 doi: 10.1007/s00415-005-0638-x – ident: e_1_3_3_48_2 doi: 10.1016/j.ajhg.2012.06.007 – ident: e_1_3_3_21_2 doi: 10.1002/humu.21438 – ident: e_1_3_3_20_2 doi: 10.1002/humu.22117 – ident: e_1_3_3_53_2 doi: 10.1038/ncomms14697 – ident: e_1_3_3_49_2 – ident: e_1_3_3_26_2 doi: 10.1038/nri1943 – ident: e_1_3_3_54_2 doi: 10.1016/j.parkreldis.2005.12.004 – ident: e_1_3_3_4_2 doi: 10.1056/NEJMoa0903753 – ident: e_1_3_3_62_2 doi: 10.1097/00001756-199909090-00008 – volume: 2 start-page: 12 year: 2015 ident: e_1_3_3_31_2 article-title: Programmed cell death and its role in inflammation publication-title: Mil. Med. Res. contributor: fullname: Yang Y. – ident: e_1_3_3_52_2 doi: 10.1093/nar/gkw971 – ident: e_1_3_3_72_2 doi: 10.1007/s10038-008-0336-5 – ident: e_1_3_3_65_2 doi: 10.1016/j.parkreldis.2007.10.003 – ident: e_1_3_3_34_2 doi: 10.1111/j.1365-2249.2006.03087.x – ident: e_1_3_3_6_2 doi: 10.1038/ncomms13760 – ident: e_1_3_3_15_2 doi: 10.1086/651559 – ident: e_1_3_3_50_2 doi: 10.1086/519795 – ident: e_1_3_3_42_2 doi: 10.1038/ng.491 – ident: e_1_3_3_14_2 doi: 10.1086/524688 – start-page: 62 volume-title: Global Leprosy Strategy 2016–2020: Accelerating towards a Leprosy-Free World–2016 Operational Manual year: 2016 ident: e_1_3_3_7_2 contributor: fullname: WHO – ident: e_1_3_3_36_2 doi: 10.1093/hmg/ddz080 – ident: e_1_3_3_33_2 doi: 10.1038/nature12555 – volume: 21 start-page: S575 year: 2006 ident: e_1_3_3_74_2 article-title: Mutation analysis of LRRK2 exon 31 and a novel P1446L mutation in Asian familial Parkinson’s disease publication-title: Mov. Disord. contributor: fullname: Tomiyama H. – ident: e_1_3_3_75_2 doi: 10.1002/mds.22514 – ident: e_1_3_3_60_2 doi: 10.1002/mds.22287 – ident: e_1_3_3_64_2 doi: 10.1111/j.1468-1331.2011.03639.x – ident: e_1_3_3_71_2 doi: 10.1016/j.neulet.2009.10.080 – ident: e_1_3_3_79_2 doi: 10.1038/srep09029 – ident: e_1_3_3_69_2 doi: 10.1002/ajmg.b.32138 – ident: e_1_3_3_73_2 doi: 10.1097/WNR.0b013e328010521c – volume-title: The International Textbook of Leprosy year: 2016 ident: e_1_3_3_1_2 contributor: fullname: Fava V. M. – ident: e_1_3_3_18_2 doi: 10.1371/journal.pgen.1006637 – ident: e_1_3_3_41_2 doi: 10.1126/science.1237908 – ident: e_1_3_3_76_2 doi: 10.1002/ana.21405 – ident: e_1_3_3_11_2 doi: 10.1093/infdis/jis208 – ident: e_1_3_3_13_2 doi: 10.1371/journal.pntd.0000231 – volume: 93 start-page: 445 year: 2018 ident: e_1_3_3_23_2 article-title: Global leprosy update, 2017: Reducing the disease burden due to leprosy publication-title: Wkly. Epidemiol. Rec. contributor: fullname: WHO – ident: e_1_3_3_35_2 doi: 10.1371/journal.pgen.1003578 – ident: e_1_3_3_58_2 doi: 10.1001/archneur.63.4.548 |
SSID | ssj0009580 |
Score | 2.5502198 |
Snippet | Type-1 reactions (T1R) are pathological inflammatory episodes and main contributors to nerve damage in leprosy. Here, we evaluate the genewise enrichment of... Type-1 reactions (T1R) are pathological immune responses in leprosy and a frequent cause of peripheral nerve damage. Employing a candidate gene approach... |
SourceID | pubmedcentral proquest crossref pubmed jstor |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 15616 |
SubjectTerms | Amino acid sequence Amino acids Biological Sciences Damage assessment Enrichment Female Genes Genetic control Humans Inflammation Kernels Leprosy Leprosy - genetics Leprosy - metabolism Leprosy - pathology Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 - genetics Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 - metabolism LRRK2 protein Male Movement disorders Mutation Neural coding Neurodegenerative diseases Parkin protein Parkinson Disease - genetics Parkinson Disease - metabolism Parkinson Disease - pathology Parkinson's disease Pathogenicity Pathogens Peripheral nerves PNAS Plus Test procedures Ubiquitin-Protein Ligases - genetics Ubiquitin-Protein Ligases - metabolism |
Title | Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease |
URI | https://www.jstor.org/stable/26848160 https://www.ncbi.nlm.nih.gov/pubmed/31308240 https://www.proquest.com/docview/2268681659 https://search.proquest.com/docview/2258738788 https://pubmed.ncbi.nlm.nih.gov/PMC6681704 |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4Bp15QgULTAjJSD_SQ3TiOE-dYIRCCghACiVOj-E-NtHhXZDn01tfg9XiSjp0foOqpx8hjy_LYmW88M58BvlimhUyojTObGXRQlIglz0WcFJYVvEYbYX1x8sVlfnqbnd3xuxXgQy1MSNpXspm42f3ENT9DbuXiXk2HPLHp1cVRnntauWy6CqtofgcXfWTaFV3dSYq_3yzNBj6fgk0Xrm4n3gIK3IrUv17EqKdr8Tcfr6xSl5j4L8j5d-bkK1N08h7WewxJvnVz3YAV4zZhoz-lLTnsqaS_bsGPq5lp5suH-aJRpE_dIAhTiS92bhypnSbfr6_PU4IfM4MzaX8RfysbU4JoMtQ8tEGq64Dg_Pn3U0v6sM4HuD05vjk6jfsXFWKFwGAZc5sJLhmt61onqkx9jJNqq3AxE8VkjeaqtFIYLZRQ1KTGllR5n6hIrE5zzbZhzc2d-QhEUqMoQ9HceySSSxwafSfNjNCi0DqCw2FFq0VHnFGFgHfBKq-H6kUPEWyHFR_lPAONoHkSwe6ggqo_Wm2FeFGg_nNeRnAwNuOh8JGO2pn5o5fhomAC3fsIdjqNjYMPKo-geKPLUcATbr9twX0YiLf7fffpv3t-hncIuMpwN5zswtry4dHsIahZyn1vUvh-2Mp_AChZ99M |
link.rule.ids | 230,314,727,780,784,885,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VcoALokAhUMBIHMohu3Ecx84RVVQL3a2qqpV6Ior_RKStd9VsD731NXg9noRx_mgRJ46Rx5blGWe-sWc-A3x0zEiVUBdnLrMYoGgZK57LOBGOCV6hj3ChOHlxnM_Os28X_GIL-FAL0ybta1VP_PJy4usfbW7l-lJPhzyx6cniIM8DrVw2fQAPORMFHYL0kWtXdpUnKf6AszQbGH0Em6591UyCD5RojDS8X8RoIGwJZx93_FKXmvgv0Pl37uQdZ3T4FJ70KJJ87ma7A1vWP4Odfp82ZL8nk_70HL6fLG292lyt1rUmffIGQaBKQrlz7UnlDZmfnh6lBD-WFmfS3JBwLhtTgniyrXpoWqmuA8LzX7c_G9Jf7LyA88MvZwezuH9TIdYIDTYxd5nkitGqqkyiizTcclLjNC5nopmq0GEVTklrpJaa2tS6guoQFYnEmTQ3bBe2_crbV0AUtZoyFM1DTKK4wqExejLMSiOFMRHsDytarjvqjLK98hasDHoo_-ghgt12xUe5wEEjaZ5EsDeooOw3V1MiYpRoATkvIvgwNuO2CHcdlber6yDDpWASA_wIXnYaGwcfVB6BuKfLUSBQbt9vQUtsqbd7y3v93z3fw6PZ2WJezr8eH72Bxwi_ivakONmD7c3VtX2LEGej3rUG_Rt_v_pC |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkRAXRIFCaAEjcSiHbOI4TpwjKqwKfWhVUaknovilRtpmo2Z74Na_wd_jlzB2HmwRJ46Rx5blGWe-8Yw_A7y3TAsZUxumNjUYoCgRSp6JMM4ty3mFPsK6y8knp9nhefr1gl9sPPXli_aVrGfN8mrW1Je-trK9UtFYJxYtTg6yzNHKpVGrbXQfHnCGRjYG6hPfruhvnyT4E06TdGT1yVnUNlU3c35QoEFS94YRo460xZ1_bPimvjzxX8Dz7_rJDYc0fwKPByRJPvYz3oZ7pnkK28Ne7cj-QCj94Rl8XyxNvVpfr9pakaGAgyBYJe7Kc92QqtHk-OzsKCH4sTQ4k-4HcWezISWIKf3Nh85L9R0Qov-6_dmRIbnzHM7nn78dHIbDuwqhQniwDrlNBZeMVlWlY1UkLtNJtVW4pLFiskKnVVgpjBZKKGoSYwuqXGSUx1YnmWY7sNWsGvMSiKRGUYaimYtLJJc4NEZQmhmhRa51APvjipZtT59R-rR3zkqnh_KPHgLY8Ss-yTkeGkGzOIC9UQXlsMG6ElGjQCvIeBHAu6kZt4bLd1SNWd04GS5yJjDID-BFr7Fp8FHlAeR3dDkJONrtuy1ojZ5-e7C-V__d8y08XHyal8dfTo924REisMIfFsd7sLW-vjGvEeWs5Rtvz78BHAr7VQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pleiotropic+effects+for+Parkin+and+LRRK2+in+leprosy+type-1+reactions+and+Parkinson%E2%80%99s+disease&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Fava%2C+Vinicius+M.&rft.au=Xu%2C+Yong+Zhong&rft.au=Lettre%2C+Guillaume&rft.au=Van+Thuc%2C+Nguyen&rft.series=PNAS+Plus&rft.date=2019-07-30&rft.pub=National+Academy+of+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=116&rft.issue=31&rft.spage=15616&rft.epage=15624&rft_id=info:doi/10.1073%2Fpnas.1901805116&rft_id=info%3Apmid%2F31308240&rft.externalDBID=PMC6681704 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon |